Skip to main content
. 2021 Jan 12;11:598353. doi: 10.3389/fphar.2020.598353

FIGURE 3.

FIGURE 3

Mizagliflozin improved cardiac function in diabetic hearts (n = 10). LVEF, left ventricular ejection fraction; LVFS, left ventricular systolic function; LVEDD, left ventricular end-diastolic dimension; LVESD, left ventricular end-systolic dimension. Values are mean ± SD, p < 0.05. *p < 0.05 versus control; # p < 0.05 versus DCM.